why bothered by the none revenue entitlement. The 260 American patients for the Next Generation AngelMed re-implantation is a damn solid affirmation for HYD and its TGA application for its Australian and other Asian markets where the cream is.
HYD Price Target $1:00 by December, page-34
Add HYD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.559M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 250000 | 2 |
View Market Depth
| Last trade - 16.12pm 09/07/2024 (20 minute delay) ? |
| HYD (ASX) Chart |
Day chart unavailable